ALL-PARTY PARLIAMENTARY GROUP FOR ETHNICITY TRANSPLANTATION AND TRANSFUSION

​

The recently formed All-Party Parliamentary Group for Ethnicity Transplantation and Transfusion announced the launch of Parliamentary Inquiry into the access to donors for those from diverse ethnic backgrounds.

Drug to treat childhood leukaemia to be made available on the NHS 

 

A cutting-edge personalised treatment for a form of childhood leukaemia is to be made available on the NHS in the first deal of its kind in Europe.

Blood test could predict leukaemia early

Researchers from Wellcome Sanger Institute and European Bioinformatics Institute (EMBL-EBI) have revealed that a blood test for changes in the DNA code can help predict a patient’s risk of developing acute myeloid leukaemia (AML) years before a positive diagnosis.​

Kymriah approved for acute lymphoblastic leukaemia

​

Novartis has announced that the European Commission (EC) has approved Kymriah® for the treatment of paediatric and young adult patients up to 25 years of age with B-cell acute lymphoblastic leukaemia (ALL).

AZ’s new leukaemia drug approved in the US

 

The FDA has approved a new cancer drug from AstraZeneca, the first medicine to treat a rare and life-threatening form of leukaemia to hit the market for 20 years. 

New campaign puts spotlight on leukaemia

​

KEIGHLEY people are being urged to learn the symptoms of leukaemia. The plea has been issued by Leukaemia Care to coincide with Blood Cancer Awareness Month.

Leukaemia scientist Dr Cristina Lo Celso given Royal Microscopical Society award

 

Dr Lo Celso is awarded the RMS Medal for Life Sciences for ‘outstanding scientific achievements applying microscopy in the field of cell biology’.